Savvidou Α, Constantinidou A, Zacharia L, et al. Real-World Data on the Use of Cyclin-Dependent Kinase 4/6 Inhibitors in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced/Metastatic Breast Cancer. World J Oncol. 2026;17(3):380-393. doi:10.14740/wjon2750